|
1
|
DiPaolo JA and Alvarez-Salas LM: Advances
in the development of therapeutic nucleic acids against cervical
cancer. Expert Opin Biol Ther. 4:1251–1264. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang J, Bai R, Li M, Ye H, Wu C, Wang C,
Li S, Tan L, Mai D, Li G, et al: Excessive miR-25-3p maturation via
N6-methyladenosine stimulated by cigarette smoke promotes
pancreatic cancer progression. Nat Commun. 10:18582019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Frank AC, Ebersberger S, Fink AF, Lampe S,
Weigert A, Schmid T, Ebersberger I, Syed SN and Brüne B: Apoptotic
tumor cell-derived microRNA-375 uses CD36 to alter the
tumor-associated macrophage phenotype. Nat Commun. 10:11352019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen Z, Zeng H, Guo Y, Liu P, Pan H, Deng
A and Hu J: miRNA-145 inhibits non-small cell lung cancer cell
proliferation by targeting c-Myc. J Exp Clin Cancer Res.
29:1512010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Wei Y, Tong H, Chen L, Fan Y, Ji
Y, Jia W, Liu D and Wang G: miR-302c-3p suppresses invasion and
proliferation of glioma cells via down-regulating metadherin (MTDH)
expression. Cancer Biol Ther. 16:1308–1315. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gu DH, Mao JH, Pan XD, Zhu H, Chen X,
Zheng B and Shan Y: microRNA-302c-3p inhibits renal cell carcinoma
cell proliferation by targeting Grb2-associated binding 2 (Gab2).
Oncotarget. 8:26334–26343. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang L, Guo Y, Liu X, Wang T, Tong X, Lei
K, Wang J, Huang D and Xu Q: The tumor suppressive miR-302c-3p
inhibits migration and invasion of hepatocellular carcinoma cells
by targeting TRAF4. J Cancer. 9:2693–2701. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Min D, Lv XB, Wang X, Zhang B, Meng W, Yu
F and Hu H: Downregulation of miR-302c and miR-520c by 1,25(OH)2D3
treatment enhances the susceptibility of tumour cells to natural
killer cell-mediated cytotoxicity. Br J Cancer. 109:723–730. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Q, Li A, Tian Y, Wu JD, Liu Y, Li T,
Chen Y, Han X and Wu K: The CXCL8-CXCR1/2 pathways in cancer.
Cytokine Growth Factor Rev. 31:61–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jia L, Li F, Shao M, Zhang W, Zhang C,
Zhao X, Luan H, Qi Y, Zhang P, Liang L, et al: IL-8 is upregulated
in cervical cancer tissues and is associated with the proliferation
and migration of HeLa cervical cancer cells. Oncol Lett.
15:1350–1356. 2018.PubMed/NCBI
|
|
13
|
Sanguinete MMM, Oliveira PH, Martins-Filho
A, Micheli DC, Tavares-Murta BM, Murta EFC and Nomelini RS: Serum
IL-6 and IL-8 correlate with prognostic factors in ovarian cancer.
Immunol Invest. 46:677–688. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yung MM, Tang HW, Cai PC, Leung TH, Ngu
SF, Chan KK, Xu D, Yang H, Ngan HY and Chan DW: GRO-α and IL-8
enhance ovarian cancer metastatic potential via the CXCR2-mediated
TAK1/NFκB signaling cascade. Theranostics. 8:1270–1285. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qu J, Cheng T, Liu L, Heng J, Liu X, Sun
Z, Wang W, Li K and Yang N: Mast cells induce
epithelial-to-mesenchymal transition and migration in non-small
cell lung cancer through IL-8/Wnt/beta-catenin pathway. J Cancer.
10:55672019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang CP, Zhou HJ, Qin J, Luo Y and Zhang
T: MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to
suppress the invasion and migration of breast cancer. Oncol Rep.
38:3144–3152. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mei Q, Xue G, Li X, Wu Z, Li X, Yan H, Guo
M, Sun S and Han W: Methylation-induced loss of miR-484 in
microsatellite-unstable colorectal cancer promotes both viability
and IL-8 production via CD137L. J Pathol. 236:165–174. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu J, Tan Q, Deng B, Fang C, Qi D and Wang
R: The microRNA-520a-3p inhibits proliferation, apoptosis and
metastasis by targeting MAP3K2 in non-small cell lung cancer. Am J
Cancer Res. 5:802–811. 2015.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu K, Pan Q, Jia LQ, Dai Z, Ke AW, Zeng
HY, Tang ZY, Fan J and Zhou J: miR-302c inhibits tumor growth of
hepatocellular carcinoma by suppressing the endothelial-mesenchymal
transition of endothelial cells. Sci Rep. 4:55242014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin C, He H, Liu H, Li R, Chen Y, Qi Y,
Jiang Q, Chen L, Zhang P, Zhang H, et al: Tumour-associated
macrophages-derived CXCL8 determines immune evasion through
autonomous PD-L1 expression in gastric cancer. Gut. 68:1764–1773.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jayatilaka H, Tyle P, Chen JJ, Kwak M, Ju
J, Kim HJ, Lee JSH, Wu PH, Gilkes DM, Fan R and Wirtz D:
Synergistic IL-6 and IL-8 paracrine signalling pathway infers a
strategy to inhibit tumour cell migration. Nat Commun. 8:155842017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li MQ, Luo XZ, Meng YH, Mei J, Zhu XY, Jin
LP and Li DJ: CXCL8 enhances proliferation and growth and reduces
apoptosis in endometrial stromal cells in an autocrine manner via a
CXCR1-triggered PTEN/AKT signal pathway. Hum Reprod. 27:2107–2116.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu YM, Webster SJ, Flower D and Woll PJ:
Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
Br J Cancer. 91:1970–1976. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li J, Wei J, Mei Z, Yin Y, Li Y, Lu M and
Jin S: Suppressing role of miR-520a-3p in breast cancer through
CCND1 and CD44. Am J Transl Res. 9:146–154. 2017.PubMed/NCBI
|
|
26
|
Wang X, Xu Y, Chen X and Xiao J: [ARTICLE
WITHDRAWN] Dexmedetomidine inhibits osteosarcoma cell proliferation
and migration, and promotes apoptosis by regulating miR-520a-3p.
Oncol Res. 26:495–502. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shathasivam P, Kollara A, Spybey T, Park
S, Clarke B, Ringuette MJ and Brown TJ: VEPH1 expression decreases
vascularisation in ovarian cancer xenografts and inhibits VEGFA and
IL8 expression through inhibition of AKT activation. Br J Cancer.
116:1065–1076. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang S, Campbell J, Stenmark MH, Zhao J,
Stanton P, Matuszak MM, Ten Haken RK and Kong FS: Plasma levels of
IL-8 and TGF-β1 predict radiation-induced lung toxicity in
non-small cell lung cancer: A validation study. Int J Radiat Oncol
Biol Phys. 98:615–621. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Liu J, Jiang Q, Deng J, Xu F, Chen
X, Cheng F, Zhang Y, Yao Y, Xia Z, et al: Human adipose-derived
mesenchymal stem cell-secreted CXCL1 and CXCL8 facilitate breast
tumor growth by promoting angiogenesis. Stem Cells. 35:2060–2070.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng J, Li Y, Liu S, Jiang Y, Ma J, Wan
L, Li Q and Pang T: CXCL8 derived from mesenchymal stromal cells
supports survival and proliferation of acute myeloid leukemia cells
through the PI3K/AKT pathway. FASEB J. 33:4755–4764. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li X, Wang Y, Wei P, Shi D, Wen S, Wu F,
Liu L, Ye N and Zhou H: Bisphenol A affects trophoblast invasion by
inhibiting CXCL8 expression in decidual stromal cells. Mol Cell
Endocrinol. 470:38–47. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tong H, Ke JQ, Jiang FZ, Wang XJ, Wang FY,
Li YR, Lu W and Wan XP: Tumor-associated macrophage-derived CXCL8
could induce ERα suppression via HOXB13 in endometrial cancer.
Cancer Lett. 376:127–136. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Osiagwu DD, Azenabor AE, Osijirin AA,
Awopetu PI and Oyegbami FR: Evaluation of interleukin 8 and
interleukin 10 cytokines in liquid based cervical cytology samples.
Pan Afr Med J. 32:1482019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yan R, Shuai H, Luo X, Wang X and Guan B:
The clinical and prognostic value of CXCL8 in cervical carcinoma
patients: Immunohistochemical analysis. Biosci Rep.
37:BSR201710212017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang W, Wu Q, Wang C, Yang L, Liu P and
Ma C: AKIP1 promotes angiogenesis and tumor growth by upregulating
CXC-chemokines in cervical cancer cells. Mol Cell Biochem.
448:311–320. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Glynn PC, Henney E and Hall IP: The
selective CXCR2 antagonist SB272844 blocks interleukin-8 and
growth-related oncogene-alpha-mediated inhibition of spontaneous
neutrophil apoptosis. Pulm Pharmacol Ther. 15:103–110. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li A, Dubey S, Varney ML, Dave BJ and
Singh RK: IL-8 directly enhanced endothelial cell survival,
proliferation, and matrix metalloproteinases production and
regulated angiogenesis. J Immunol. 170:3369–3376. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Eitel J, Heise T, Thiesen U and Dersch P:
Cell invasion and IL-8 production pathways initiated by YadA of
Yersinia pseudotuberculosis require common signalling molecules
(FAK, c-Src, Ras) and distinct cell factors. Cell Microbiol.
7:63–77. 2005. View Article : Google Scholar : PubMed/NCBI
|
